Exceptional Responses to Selpercatinib in <i>RET</i> Fusion-Driven Metastatic Pancreatic Cancer.

ABSTRACT:

SUBMITTER: Bhamidipati D 

PROVIDER: S-EPMC11756707 | biostudies-literature | 2023 Sep

REPOSITORIES: biostudies-literature